Consulting firm McKinsey & Company has agreed to pay $650m to resolve a United States Department of Justice investigation into the consulting firm’s work advising opioid manufacturer Purdue ...

McKinsey & Co has agreed to pay $650 million to resolve a US Department of Justice investigation into the consulting firm’s work advising opioid manufacturer OxyContin maker Purdue Pharma on how ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe ...

NBC News and CNBC, citing court filings, reported Friday morning that McKinsey has agreed to pay $650 million in a five-year deferred prosecution agreement that will resolve a federal criminal ...

Consulting giant McKinsey & Company will pay $650 million to settle US criminal charges that it collaborated with Purdue Pharma to intentionally misbrand opioids, worsening a public health crisis ...

McKinsey enters five-year deferred prosecution agreement Ex-partner Martin Elling to plead guilty to obstruction McKinsey to improve compliance and resolve civil probe BOSTON, Dec 13 (Reuters ...

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work advising Purdue Pharma on how to ...

The United States Attorney's Office alongside other federal officials on Friday announced the resolution of criminal and civil investigations into McKinsey & Company's work with Purdue Pharma.

The United States Attorney's Office plans to announce the resolution of criminal and civil investigations into McKinsey & Company's work with Purdue Pharma on Friday. A press conference will be ...